Balloon angioplasty has been shown to be superior to medical treatment for the relief of symptoms and ischemia in patients with single vessel coronary artery disease. Unfortunately, the outcome of PTCA in women has not been as favorable as the outcome in men. Women tend to be older than men at the time of angioplasty and are less likely than men to remain symptom free during serial follow-up. Furthermore, the long-term outcome of PTCA is compromised in all patients by restenosis which occurs in 30- 50% of patients within 3-6 months of the initial procedure. Since angioplasty is performed on over 120,000 women each year in the United States, restenosis in 30-50% of these patients represents a significant public health problem for older women. A variety of metallic intra- coronary stents have been employed in an attempt to improve PTCA success rates. These devices have been shown to enhance post-PTCA lesion geometry and to improve long-term outcome in comparison to PTCA. Nevertheless restenosis still occurs in 22% and 32% of stented patients. Thus, in spite of significant advances in technique and adjunctive medical treatment, restenosis after percutaneous coronary revascularization remains a major problem. Moreover, women have fared comparatively poorly after PTCA with less long-term relief of symptoms and a trend towards reduced survival compared to men. Interestingly, two recent retrospective studies have suggested that women who took estrogen replacement after their angioplasty had less restenosis and better long- term outcome than their non-estrogen taking counterparts. Accordingly, the primary goal of this Proposal is to investigate the potential of estrogen replacement therapy to inhibit restenosis after angioplasty and stenting in older women. Coronary heart disease is the leading cause of depth among post-menopausal women. This is in stark contrast to the relative freedom from coronary disease which is enjoyed by most pre- menopausal women. Elucidation of the effect of estrogen on the arterial response to coronary stenting will provide important insights into the mechanisms of the atherosclerotic disease process itself, as well as providing the opportunity to understand how best to extend the protection enjoyed by pre-menopausal women into women in older age groups, as well as into the male population.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Research Project (R01)
Project #
Application #
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Program Officer
Premen, Andre J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Steward St. Elizabeth's Medical Center
United States
Zip Code
Magnusson, Kathy Ruth; Das, Siba Ranjan; Kronemann, Daniel et al. (2011) The effects of aging and genotype on NMDA receptor expression in growth hormone receptor knockout (GHRKO) mice. J Gerontol A Biol Sci Med Sci 66:607-19
Losordo, Douglas W; Kishore, Raj (2009) A big promise from the very small identification of circulating embryonic stem-like pluripotent cells in patients with acute myocardial infarction. J Am Coll Cardiol 53:10-2
Jujo, Kentaro; Ii, Masaaki; Losordo, Douglas W (2008) Endothelial progenitor cells in neovascularization of infarcted myocardium. J Mol Cell Cardiol 45:530-44
Kirchmair, Rudolf; Walter, Dirk H; Ii, Masaaki et al. (2005) Antiangiogenesis mediates cisplatin-induced peripheral neuropathy: attenuation or reversal by local vascular endothelial growth factor gene therapy without augmenting tumor growth. Circulation 111:2662-70
Weis, Sara; Shintani, Satoshi; Weber, Alberto et al. (2004) Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest 113:885-94
Pola, Roberto; Ling, Leona E; Aprahamian, Tamar R et al. (2003) Postnatal recapitulation of embryonic hedgehog pathway in response to skeletal muscle ischemia. Circulation 108:479-85
Spyridopoulos, Ioakim; Luedemann, Corinne; Chen, Donghui et al. (2002) Divergence of angiogenic and vascular permeability signaling by VEGF: inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeability. Arterioscler Thromb Vasc Biol 22:901-6
Isner, J M; Vale, P R; Symes, J F et al. (2001) Assessment of risks associated with cardiovascular gene therapy in human subjects. Circ Res 89:389-400
Krasinski, K; Spyridopoulos, I; Kearney, M et al. (2001) In vivo blockade of tumor necrosis factor-alpha accelerates functional endothelial recovery after balloon angioplasty. Circulation 104:1754-6
Amant, C; Holm, P; Xu Sh, S H et al. (2001) Estrogen receptor-mediated, nitric oxide-dependent modulation of the immunologic barrier function of the endothelium: regulation of fas ligand expression by estradiol. Circulation 104:2576-81

Showing the most recent 10 out of 11 publications